Your browser doesn't support javascript.
loading
Trastuzumab Emtansine for Treating HER2-Positive, Unresectable, Locally Advanced or Metastatic Breast Cancer After Treatment with Trastuzumab and a Taxane: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Squires, Hazel; Stevenson, Matt; Simpson, Emma; Harvey, Rebecca; Stevens, John.
Affiliation
  • Squires H; University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK. h.squires@sheffield.ac.uk.
  • Stevenson M; University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Simpson E; University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Harvey R; University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
  • Stevens J; University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.
Pharmacoeconomics ; 34(7): 673-80, 2016 07.
Article in En | MEDLINE | ID: mdl-26892972

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal, Humanized / Maytansine Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal, Humanized / Maytansine Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Type: Article Affiliation country: United kingdom